Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort.
Pelle J, Briant AR, Branger P, Derache N, Arnaud C, Lebrun-Frenay C, Cohen M, Mondot L, De Seze J, Bigaut K, Collongues N, Kremer L, Ricard D, Bompaire F, Ohlmann C, Sallansonnet-Froment M, Ciron J, Biotti D, Pignolet B, Parienti JJ, Defer G.
Pelle J, et al. Among authors: mondot l.
Neurol Ther. 2023 Apr;12(2):529-542. doi: 10.1007/s40120-023-00440-5. Epub 2023 Feb 10.
Neurol Ther. 2023.
PMID: 36763307
Free PMC article.